Microcephaly, an etiopathogenic vision
Luis Eduardo Becerra-Solano1, Leovigildo Mateos-Sánchez2, Eunice López-Muñoz1
1Medical Research Unit in Reproductive Medicine, Unidad Médica de Alta Especialidad, Hospital de Gineco Obstetricia No. 4, "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social, Río Magdalena 289, Level 6, Laboratory K, Colonia Tizapan San Ángel, Alcaldía Álvaro Obregón, C.P. 01090, Mexico City, Mexico.
Abstract:
Microcephaly is defined by an occipital-frontal head circumference (OFD) 2 standard deviations (SD) smaller than the average expected for age, gender and population. Its incidence has been reported between 1.3 and 150 cases per 100,000 births. Currently, new clinical characteristics, causes and pathophysiological mechanisms related to microcephaly continue to be identified. Its etiology is varied and heterogeneous, with genetic and non-genetic factors that produce alterations in differentiation, proliferation, migration, repair of damage to deoxyribonucleic acid and neuronal apoptosis. It requires a multidisciplinary diagnostic approach that includes a medical history, detailed prenatal and postnatal clinical evaluation, cerebral magnetic resonance imaging, neuropsychological evaluation, and in some cases complementary tests such as metabolic screening, tests to rule out infectious processes and genetic testing. There is no specific treatment or intervention to increase cerebral growth; however, timely intervention strategies and programs can be established to improve motor and neurocognitive development, as well as to provide genetic counseling. The objective of this work is to review the available information and reinforce the proposal to carry out an etiopathogenic approach for microcephaly diagnosis and management.
Insights
Microcephaly, a condition of reduced head size, has diverse causes including genetic and environmental factors. Early diagnosis and management are crucial for improving neurodevelopmental outcomes.
Area of Science:
- Neurology
- Genetics
- Developmental Biology
Background:
- Microcephaly is defined as an occipital-frontal head circumference (OFD) 2 standard deviations (SD) below the population average.
- Incidence rates vary widely, from 1.3 to 150 cases per 100,000 births.
- Etiology is heterogeneous, involving genetic and non-genetic factors impacting brain development.
Purpose of the Study:
- To review current information on microcephaly.
- To reinforce the need for an etiopathogenic approach in diagnosis and management.
- To highlight the multidisciplinary diagnostic requirements.
Main Methods:
- Review of available scientific literature on microcephaly.
- Analysis of diagnostic approaches including medical history, clinical evaluation, neuroimaging, and genetic testing.
- Discussion of pathophysiological mechanisms and intervention strategies.
Main Results:
- Identified varied genetic and non-genetic causes affecting neuronal processes (differentiation, proliferation, migration, DNA repair, apoptosis).
- Emphasized the necessity of a multidisciplinary diagnostic approach.
- Confirmed the absence of specific treatments to increase brain growth but highlighted the importance of early interventions.
Conclusions:
- An etiopathogenic approach is essential for effective microcephaly diagnosis and management.
- Timely interventions can improve motor and neurocognitive development.
- Genetic counseling is a key component of management.
More Related Videos
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Teratogenicity
Fungal Phylum Microsporidia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...


